Immunology. Therapeutic manipulation of gut flora.
Shanahan, F
Shanahan, F
Author
Advisors
Editors
Other Contributors
Date
2012-02-03T15:12:36Z
Date Submitted
Keywords
Other Subjects
Subject Mesh
Animals
Genetic Engineering
Humans
Immunity, Mucosal
Inflammatory Bowel Diseases/*immunology/*therapy
Interleukin-10/administration & dosage/*biosynthesis/genetics/immunology
Intestinal Mucosa/immunology/microbiology
Intestines/immunology/*microbiology
Lactococcus lactis/*genetics/immunology/metabolism
Mice
Probiotics/*therapeutic use
Recombinant Proteins/administration & dosage/biosynthesis/immunology
T-Lymphocyte Subsets/immunology
Genetic Engineering
Humans
Immunity, Mucosal
Inflammatory Bowel Diseases/*immunology/*therapy
Interleukin-10/administration & dosage/*biosynthesis/genetics/immunology
Intestinal Mucosa/immunology/microbiology
Intestines/immunology/*microbiology
Lactococcus lactis/*genetics/immunology/metabolism
Mice
Probiotics/*therapeutic use
Recombinant Proteins/administration & dosage/biosynthesis/immunology
T-Lymphocyte Subsets/immunology
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
In developed countries as many as two individuals in every thousand suffer from inflammatory bowel disease (ulcerative colitis and Crohn's disease). In his Perspective, Shanahan discusses a new therapeutic approach to treating these conditions in which bacteria normally found in the gut are engineered to produce the anti-inflammatory cytokine interleukin-10 and then are fed as probiotics to mice with these disorders (Steidler et al.).
Language
eng
ISSN
0036-8075 (Print)
0036-8075 (Linking)
0036-8075 (Linking)
eISSN
ISBN
DOI
PMID
10979858
